Biotech Pulse
Source: COVID-19 image by Getty Images; edits by PrudentBiotech.com
It has taken a pandemic for biotechs to take flight towards their all-time high.
One of the first industry groups to recover from the virus-related selloff and be neutral for the year, biotech indexes have gained strength as they move towards or make new 52-week highs. The Nasdaq Biotechnology Index, which is heavily weighted towards larger cap biotechs like Gilead (GILD), Vertex (VRTX), and Amgen (AMGN), may finally be positioned to achieve an all-time high, eclipsing the